Skin rash composition after checkpoint inhibitor therapy varies by therapeutic regimen
Published: 5 May 2022| Version 1 | DOI: 10.17632/hw4j2k8xt3.1
Bethany Perez White,
I. Caroline Le Poole
Patient skin rash and control cell counts.
Steps to reproduce
Obtain human patient control and rash skin. Section and fix tissues appropriately. Conduct immunoenzymatic or immunofluorescent stainings, calculate area, and use microscopy to evaluate and quantify.
Northwestern University - Chicago
Immunotherapy, T Cell, Skin Rash, Immune Checkpoint Inhibitor